Crism Therapeutics Corporation (CRTX) News

Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect t

CARY, N.C., July 8 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX) announced today that it will hold a special meeting of...

UPDATE:FDA Updates Singulair Label For Neuropsychiatric Events

The U.S. Food and Drug Administration said Friday it was updating the label of Merck & Co.'s (MRK) Singulair and similar asthma medications to...

FDA: Updates Singulair Label For Neuropsychiatric Events

The U.S. Food and Drug Administration said Friday it was updating the label of Merck & Co.'s (MRK) Singulair and similar asthma medications to...

Cornerstone Therapeutics Announces Management Change

CARY, N.C., May 19 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), formerly known as Critical Therapeutics, Inc., a...

Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA

- CORNERSTONE GAINS EXCLUSIVE 10-YEAR LICENSE FOR U.S. COMMERCIAL RIGHTS TO MARKETED RESPIRATORY DRUG, CUROSURF(R), AND RECEIVES CASH PROCEEDS OF...

Cornerstone Therapeutics Reports First Quarter 2009 Financial Results

CARY, N.C., May 7 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on...

Cornerstone Therapeutics to Host First Quarter 2009 Conference Call

CARY, N.C., April 27 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NasdaqCM: CRTX), a specialty pharmaceutical company focused on...

UPDATE: Singular, Zyflo Asthma Drug Safety Review Continues

The U.S. Food and Drug Administration said Tuesday it's continuing a safety review of Singulair and similar asthma medications to see if they are...

FDA: Singular, Zyflo Asthma Drug Safety Review Continues

The U.S. Food and Drug Administration said Tuesday it's continuing a safety review of Singulair and similar asthma medications to see if they are...

Cornerstone Therapeutics Announces New Board of Directors

CARY, N.C., Nov. 5 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTXD)*, a specialty pharmaceutical company focused on...

Critical Therapeutics Files Controlled Release Formulation of Zileuton